Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2001 | 2014 | ||||||||
|
signal transducer and activator of transcription 1 | 0.399 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||||||
|
glycoprotein Ib platelet subunit beta | 0.524 | 0.769 | 0.51 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2004 | 2019 | ||||||||
|
glycoprotein IX platelet | 0.695 | 0.500 | 0.48 |
|
phenotype | 0.460 | None | 1.000 | 1 | 1 | 1998 | 2020 | ||||||||
|
integrin subunit alpha 2b | 0.493 | 0.692 | 1.5E-16 |
|
phenotype | 0.450 | None | 1.000 | 1 | 1 | 1998 | 2019 | ||||||||
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 0.610 | 0.692 | 2.5E-16 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
phenotype | 0.400 | None | 1.000 | 1 | 3 | 1998 | 2020 | ||||||||
|
septin 5 | 0.691 | 0.462 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
WASP actin nucleation promoting factor | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 1 | 2002 | 2019 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
phenotype | 0.140 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
cholinergic receptor nicotinic epsilon subunit | 0.636 | 0.577 | 4.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
clathrin light chain A | 0.628 | 0.654 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.200 | None | 1.000 | 1 | 2 | 2011 | 2019 | ||||||||
|
elongation factor like GTPase 1 | 0.638 | 0.577 | 5.1E-08 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
tripartite motif containing 25 | 0.633 | 0.462 | 4.1E-03 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
stromal antigen 2 | 0.568 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
diacylglycerol kinase epsilon | 0.674 | 0.538 | 5.5E-06 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
ELOVL fatty acid elongase 4 | 0.601 | 0.577 | 0.83 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.200 | None | 1.000 | 0 | 2 | 2002 | 2019 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 1 | 2016 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
phenotype | 0.130 | None | 1.000 | 0 | 2 | 2004 | 2017 | ||||||||
|
phosphomannomutase 2 | 0.535 | 0.769 | 1.4E-17 |
|
phenotype | 0.100 | None | 0 | 2 | |||||||||||
|
Fli-1 proto-oncogene, ETS transcription factor | 0.468 | 0.692 | 0.99 |
|
phenotype | 0.200 | None | 0.933 | 0 | 1 | 2000 | 2019 |